Overcoming Obstacles to Timely Access to Evidence-Based Treatments for Patients With Inflammatory Bowel Disease

Overcoming Obstacles to Timely Access to Evidence-Based Treatments for Patients With Inflammatory Bowel Disease

Watch this video to learn about effective tools and strategies to improve timely access to needed evidence-based therapies for your patients with inflammatory bowel disease (IBD). Expert faculty will discuss the latest data for these treatments and the identification of patients that would benefit from them. Participants will gain access to a point-of-care resource designed to assist IBD patients in navigating insurance issues. Key insights from a pilot implementation study of clinics that utilized this guide and developed action plans to improve access to needed therapies will also be shared.

  • Provider:PRIME Education, Inc. (PRIME®)
  • Activity Link: https://primeinc.org/online/overcoming-obstacles-timely-access-evidence-based-treatments-patients
  • Start Date: 2024-05-08 05:00:00
  • End Date: 2024-05-08 05:00:00
  • Credit Details: IPCE Credits: 0.5 hours
    AAPA Category 1 Credit™️: 0.5 hours
    AMA PRA Category 1 Credit™️: 0.5 hours
    Nursing: 0.5 hours
    Pharmacy: 0.5 hours
  • Commercial Support: Source: Takeda Pharmaceuticals (Any division) - Amount: 64750.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner/Team Competence, Learner/Team Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.